Cero Therapeutics receives FDA clearance of IND application for CER-1236
CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...
GE HealthCare to hold investor day
Investor Day to be held in New York on November 21 at 8 am. Webcast Link Published first on TheFly – the ultimate source for real-time, ...